Copenhagen - Delayed Quote DKK

Novo Nordisk A/S (NOVO-B.CO)

903.30

-9.60

(-1.05%)

At close: May 17 at 4:59 PM GMT+2

Microsoft Leads Five Stocks Near Buy Points As Market Flashes Green

Microsoft is near a buy point with the market rally flashing green. It's one of five stocks to watch.

Investor's Business Daily 12 hours ago

MSFT

NVO

APO-PA
3 Monster Stocks in the Making You Can Buy Right Now

These stocks might not be small for too much longer.

Motley Fool 14 hours ago

VKTX

AXSM

NVO
Is Novo Nordisk Stock a Millionaire Maker?

Novo Nordisk's stock may look expensive today, but that may not be the case in even a year or two.

Motley Fool 18 hours ago

NVO
Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates

Bayer (BAYRY) releases Q1 results. J&J (JNJ) set to acquire private biotech, Proteologix, which will add atopic dermatitis candidates.

Zacks yesterday

BAYRY

LLY

NVO
Novo Nordisk A/S - share repurchase programme

Bagsværd, Denmark, 17 May 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. Under the programme initiate

GlobeNewswire yesterday

NONOF

NVO
4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly

Though obesity drugs continue to gain traction, it is currently a duopoly market. As analysts expect demand to grow at an encouraging pace, several biotech/pharma companies are rushing to enter this space.

Zacks yesterday

VKTX

NVO

ROG.SW
Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Novo Nordisk (NVO). This makes it worthwhile to examine what the stock has in store.

Zacks yesterday

NVO
Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk

Could Amgen be the next stock to soar due to a GLP-1 drug?

Motley Fool yesterday

AMGN

LLY

NVO
Dow Jones hits record milestone as US bets on faster rate cuts

The Dow Jones Industrial Average hit a record 40,000 this afternoon, seen as a major milestone for the index which tracks 30 of America’s top companies.

The Telegraph 2 days ago

^DJI

^FTSE

COMP
Ozempic drives economic boom in Denmark as growth forecasts doubled

Booming demand for Ozempic is driving a surge in Denmark’s economy as millions of people use the drug for weight loss, leading the government to almost double its growth forecast for this year.

The Telegraph 2 days ago

NVO
Denmark enjoys ‘Nokia moment’ as Ozempic flies off the shelves

Booming demand for Ozempic is driving a surge in Denmark’s economy as millions of people use the drug for weight loss, leading the government to almost double its growth forecast for this year.

The Telegraph 2 days ago

NVO
Fire at Novo Nordisk Construction Site Gives Investors A Scare

A fire broke out Thursday on the roof of a new building under construction at a Novo Nordisk manufacturing site in Kalundborg, Denmark, where the drug maker is expanding capacity for its popular diabetes and weight-loss drugs. The company’s American depositary receipts were down 1.28% in morning trading. “We are optimistic that it will not impact production timelines.”

The Wall Street Journal 2 days ago

NONOF

NVO
3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance

Here we discuss three drugmakers, Eli Lilly and Company (LLY), Novo Nordisk (NVO) and Merck (MRK), that have raised their earnings as well as sales guidance for 2024.

Zacks 2 days ago

LLY

NVO
Roche (RHHBY) Posts Encouraging Phase I Obesity Drug Data

Data from the study shows that nearly half of the patients who received Roche's (RHHBY) subcutaneously-administered obesity drug lost more than 20% of their body weight after 24 weeks.

Zacks 2 days ago

ROG.SW

LLY

NVO
Lilly’s once-weekly insulin matches daily shots in late-stage tests

The results, which showed Lilly’s drug was as effective at controlling blood sugar as standard injections, come as Novo Nordisk seeks approval for a competing once-weekly insulin.

BioPharma Dive 2 days ago

LLY

NVO
Novo Nordisk Weigh-Loss Drugs Could Bankrupt US Health Care, Senate Committee Report Says

Novo Nordisk Weigh-Loss Drugs Could Bankrupt US Health Care, Senate Committee Report Says

PREMIUM
MT Newswires 3 days ago

NVO
No Wegovy Shortage in Denmark Amid High Demand, Novo Nordisk Confirms

Novo Nordisk A/S (NYSE:NVO) says that despite earlier warnings from the Danish Medicines Agency about potential shortages of Wegovy, it does not anticipate a shortage of its weight-loss drug in Denmark. The agency had warned of limited supply for the 1 mg injection pen from late May to mid-June and the 0.5 mg injection pen from mid-June to mid-July due to increased demand. Also Read: What Are Pricing Strategies for Ozempic And Wegovy With Potential Medicare Coverage Expansion? Senate Committee Q

Benzinga 3 days ago

NVO
Eli Lilly Strikes Deal To Combat Counterfeit Diabetes And Weight Loss Drugs Mounjaro And Zepbound

Eli Lilly And Co (NYSE:LLY) has reportedly reached a settlement agreement with a medi spa that sold counterfeit versions of its popular diabetes drug Mounjaro and weight loss treatment Zepbound, which contains tirzepatide. As part of the deal, Totality Medispa will pay Lilly a monetary payment and cease using Lilly’s branding to promote its products. In addition to the financial settlement, Totality Medispa is required to take corrective actions, including ensuring that any compounded tirzepatid

Benzinga 3 days ago

LLY

NVO
Should You Hold Viking Therapeutics (VKTX) in Your Portfolio?

Viking Therapeutics' (VKTX) lead candidate for obesity, VK2735, is expected to have tremendous potential. However, existing competition from obesity drugs in the market remains a woe.

Zacks 3 days ago

VKTX

NVO

LLY
Is Eli Lilly Stock A Buy Or A Sell With Key Alzheimer's Meeting Looming?

Eli Lilly stock broke out and then retreated into sell-zone territory. With shares on the rise again, is LLY stock a buy?

Investor's Business Daily 3 days ago

LLY

NVO

BIIB

Performance Overview

Return	NOVO-B.CO	OMX Copenhagen 25 Index
YTD	+30.33%	+7.58%
1-Year	+59.62%	+5.09%
3-Year	+292.72%	0.00%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Novo Nordisk A/S (NOVO-B.CO)

Microsoft Leads Five Stocks Near Buy Points As Market Flashes Green

3 Monster Stocks in the Making You Can Buy Right Now

Is Novo Nordisk Stock a Millionaire Maker?

Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates

Novo Nordisk A/S - share repurchase programme

4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly

Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know

Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk

Dow Jones hits record milestone as US bets on faster rate cuts

Ozempic drives economic boom in Denmark as growth forecasts doubled

Denmark enjoys ‘Nokia moment’ as Ozempic flies off the shelves

Fire at Novo Nordisk Construction Site Gives Investors A Scare

3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance

Roche (RHHBY) Posts Encouraging Phase I Obesity Drug Data

Lilly’s once-weekly insulin matches daily shots in late-stage tests

Novo Nordisk Weigh-Loss Drugs Could Bankrupt US Health Care, Senate Committee Report Says

No Wegovy Shortage in Denmark Amid High Demand, Novo Nordisk Confirms

Eli Lilly Strikes Deal To Combat Counterfeit Diabetes And Weight Loss Drugs Mounjaro And Zepbound

Should You Hold Viking Therapeutics (VKTX) in Your Portfolio?

Is Eli Lilly Stock A Buy Or A Sell With Key Alzheimer's Meeting Looming?

Performance Overview